Manufacturing, Monoclonal Antibodies

Improving the Fate of ADCs

November 02, 2022

Learning from early market failures, the biopharma industry has worked to improve the fate of antibody drug conjugates.

Streamlining Bulk mAb Manufacturing

September 02, 2022

The projected growth in the biosimilars market will require increased bulk mAb manufacturing.

Approaches to Scaling Up Chromatography Processes

September 01, 2022

Scaling up chromatography resins requires a thorough understanding of their intended use.

Continuous Processing for Viral Vectors

August 01, 2022

Manufacturers are taking the first steps toward process intensification.

MilliporeSigma’s ZooMAb Antibodies Earn ACT Label from My Green Lab

May 09, 2022

MilliporeSigma’s ZooMAb antibodies have been recognized for their low environmental impact by My Green Lab.

Large-Scale Single-Use Bioreactors Can Maximize Long-Term Scale Up

April 02, 2022

The growing demand for antibody and other bio-therapeutics will require long-term scale-up solutions.

What’s New in Downstream Processing?

April 01, 2022

The past year of downstream processing has brought innovations in pH sensitive antibody purification, single-use fermentation separators, and more.

AstraZeneca’s Antibody Combination Authorized for Use in Great Britain for Prevention of COVID-19

March 21, 2022

AstraZeneca’s antibody combination has been authorized for use in Great Britain to prevent COVID-19 in high-risk populations and people for whom vaccination may not be effective.

Adagene Announces Collaboration with Sanofi for Novel Masked Immuno-Oncology Antibody Candidates

March 02, 2022

Adagene has announced SAFEbody multi-target collaboration with Sanofi for novel masked immuno-oncology antibody candidates.

Outlining Cell Lines’ Future with Engineering Approaches

March 02, 2022

The use of bioengineering offers practical tools for the evolution of host cells.